10 Must-Read Articles For #ECTRIMS2015

Isaura Santos avatar

by Isaura Santos |

Share this article:

Share article via email

Here is what you need to read before #ECTRIMS2015

1.       Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?

 

2.      Ocrelizumab: a Promising New Treatment for Multiple Sclerosis with Minimal Side Effects

 

3.      Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients

 

4.      Biogen to Present New Data at Upcoming ECTRIMS 2015 Congress on MS Therapies, Including TECFIDERA

 

5.      EMD Serono To Present New Data on Rebif, a Therapy for RRMS, at Upcoming ECTRIMS Congress

 

6.      Receptos Launches SUNBEAM Phase 3 Trial for Relapsing Multiple Sclerosis Therapy

 

7.      Gut Bacteria: Key to MS?

 

8.      Most MS Survey Respondents Favor Legal Marijuana Access For Medical Use

 

9.      Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial

 

10.    Study Supports High Intensity Exercise to Improve Muscle Condition in MS Patients

 

Updates on #ECTRIMS2015

Print This Page

About the Author

Isaura Santos avatar
Isaura Santos Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Tags

ECTRIMS2015

Recent Posts

Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.

Listen Here


Recommended reading